Van ECK Associates Corp Takes $4.48 Million Position in Corcept Therapeutics Incorporated (NASDAQ:CORT)
Van ECK Associates Corp purchased a new stake in Corcept Therapeutics Incorporated (NASDAQ:CORT – Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 88,966 shares of the biotechnology company’s stock, valued at approximately $4,483,000. A number of other institutional investors also recently […]
Van ECK Associates Corp purchased a new stake in Corcept Therapeutics Incorporated (NASDAQ:CORT – Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 88,966 shares of the biotechnology company’s stock, valued at approximately $4,483,000. A number of other institutional investors also recently […]
